Charles Schwab Investment Management Inc. decreased its holdings in shares of MultiPlan Co. (NYSE:MPLN - Free Report) by 38.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,404 shares of the company's stock after selling 47,110 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.47% of MultiPlan worth $1,114,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Empowered Funds LLC grew its holdings in MultiPlan by 5.0% during the 4th quarter. Empowered Funds LLC now owns 46,191 shares of the company's stock worth $683,000 after acquiring an additional 2,188 shares during the period. Beach Point Capital Management LP grew its stake in shares of MultiPlan by 9.2% during the fourth quarter. Beach Point Capital Management LP now owns 384,982 shares of the company's stock worth $5,690,000 after purchasing an additional 32,582 shares during the period. Finally, Oppenheimer & Co. Inc. bought a new stake in MultiPlan in the fourth quarter valued at about $292,000. 87.15% of the stock is owned by institutional investors.
MultiPlan Stock Performance
NYSE:MPLN traded up $0.07 during trading hours on Thursday, hitting $20.70. The stock had a trading volume of 42,106 shares, compared to its average volume of 109,278. The firm has a 50 day moving average price of $21.53. The company has a debt-to-equity ratio of 21.73, a quick ratio of 1.05 and a current ratio of 1.05. The stock has a market cap of $334.74 million, a P/E ratio of -0.22 and a beta of 0.13. MultiPlan Co. has a one year low of $4.80 and a one year high of $35.96.
Analyst Ratings Changes
Separately, Citigroup raised their target price on MultiPlan from $10.00 to $12.50 and gave the stock a "neutral" rating in a report on Friday, January 10th.
View Our Latest Analysis on MultiPlan
MultiPlan Profile
(
Free Report)
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Recommended Stories
Before you consider MultiPlan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.
While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
